Amphastar P Stock Performance

AMPH Stock  USD 20.23  6.26  23.63%   
The firm shows a Beta (market volatility) of 1.99, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Amphastar will likely underperform. At this point, Amphastar P has a negative expected return of -0.37%. Please make sure to confirm Amphastar's accumulation distribution, and the relationship between the value at risk and day typical price , to decide if Amphastar P performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Amphastar P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more

Actual Historical Performance (%)

One Day Return
(23.63)
Five Day Return
(28.82)
Year To Date Return
(23.54)
Ten Year Return
80.63
All Time Return
131.2
1
Disposition of 2426 shares by Petersen Floyd F. of Amphastar at 25.9226 subject to Rule 16b-3
12/12/2025
2
A Fresh Look at Amphastar Pharmaceuticals Valuation After Recent Share Price Stabilisation
12/23/2025
3
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compou...
01/12/2026
4
1 Profitable Stock Worth Your Attention and 2 Facing Headwinds - The Globe and Mail
01/13/2026
5
Why Amphastar Pharmaceuticals Stock Is Nosediving
01/15/2026
6
CorMedix vs. Mirum Pharma Which Rare-Disease Stock is the Better Buy
01/20/2026
7
CRMD Down 31 percent in a Month Is This an Indication to Sell the Stock
01/30/2026
8
Acquisition by Gaugh David Russell of 6304 shares of Amphastar subject to Rule 16b-3
02/04/2026
9
3 Stocks Under 50 with Warning Signs
02/05/2026
10
Amphastar Pharmaceuticals, Inc. AMPH Shares Bought by New York State Common Retirement Fund - MarketBeat
02/09/2026
11
Acquisition by Peters William J of 780 shares of Amphastar at 28.41 subject to Rule 16b-3
02/13/2026
12
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
02/20/2026
Begin Period Cash Flow144.5 M
Total Cashflows From Investing Activities-124.9 M

Amphastar Relative Risk vs. Return Landscape

If you would invest  2,667  in Amphastar P on December 2, 2025 and sell it today you would lose (644.00) from holding Amphastar P or give up 24.15% of portfolio value over 90 days. Amphastar P is currently does not generate positive expected returns and assumes 3.8069% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Amphastar, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Amphastar is expected to under-perform the market. In addition to that, the company is 5.03 times more volatile than its market benchmark. It trades about -0.1 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Amphastar Target Price Odds to finish over Current Price

The tendency of Amphastar Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 20.23 90 days 20.23 
close to 99
Based on a normal probability distribution, the odds of Amphastar to move above the current price in 90 days from now is close to 99 (This Amphastar P probability density function shows the probability of Amphastar Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.99 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Amphastar will likely underperform. Additionally Amphastar P has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Amphastar Price Density   
       Price  

Predictive Modules for Amphastar

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amphastar P. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
16.5820.3724.16
Details
Intrinsic
Valuation
LowRealHigh
19.4423.2327.02
Details
Naive
Forecast
LowNextHigh
14.3618.1521.94
Details
6 Analysts
Consensus
LowTargetHigh
26.9129.5732.82
Details

Amphastar Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Amphastar is not an exception. The market had few large corrections towards the Amphastar's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amphastar P, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amphastar within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.47
β
Beta against Dow Jones1.99
σ
Overall volatility
1.33
Ir
Information ratio -0.11

Amphastar Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amphastar for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amphastar P can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Amphastar P generated a negative expected return over the last 90 days
Amphastar P has high historical volatility and very poor performance
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026

Amphastar Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amphastar Stock often depends not only on the future outlook of the current and potential Amphastar's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amphastar's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding48.2 M
Cash And Short Term Investments282.8 M

Amphastar Fundamentals Growth

Amphastar Stock prices reflect investors' perceptions of the future prospects and financial health of Amphastar, and Amphastar fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amphastar Stock performance.

About Amphastar Performance

By evaluating Amphastar's fundamental ratios, stakeholders can gain valuable insights into Amphastar's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Amphastar has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Amphastar has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1761 people.

Things to note about Amphastar P performance evaluation

Checking the ongoing alerts about Amphastar for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amphastar P help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Amphastar P generated a negative expected return over the last 90 days
Amphastar P has high historical volatility and very poor performance
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
Evaluating Amphastar's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Amphastar's stock performance include:
  • Analyzing Amphastar's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amphastar's stock is overvalued or undervalued compared to its peers.
  • Examining Amphastar's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Amphastar's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amphastar's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Amphastar's stock. These opinions can provide insight into Amphastar's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Amphastar's stock performance is not an exact science, and many factors can impact Amphastar's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Amphastar Stock analysis

When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope